Background/Objectives: Health effects of whole grain foods are becoming more evident. In this study, we analysed the shortchain fatty acid profiles in urine and serum derived from the colonic fermentation process of 13 C-barley meals, prepared from barley grown under 13 CO 2 atmosphere. Subjects/Methods: In a crossover study, five volunteers ingested intact barley kernels (high content of non-starch polysaccharides (NSP) and resistant starch (RS)) and barley porridge (high content of NSP only). Using a newly developed stable isotope technology, we monitored 14 and 24 h postprandially 13 C-acetate, 13 C-propionate and 13 C-butyrate in plasma and urine, respectively. The oro-cecal transit time (OCTT) of the meals was measured with the hydrogen breath test. Results: The OCTT was 6 h and did not differ between the two test meals. An increase of 13 C-acetate was observed already early after ingestion of the meals (o6 h) and was attributed to early fermentation of the test meal. A rise in plasma 13 C-propionate in the fermentation phase could only be detected after the porridge and not after the kernel meal. An increase in 13 C-butyrate was only found in the fermentation phase and was higher after the barley kernels. Urine 13 C-short-chain fatty acids data were consistent with these observations. Conclusions: The difference in the profiles of 13 C-acetate, 13 C-propionate and 13 C-butyrate indicates that NSP combined with RS results in an altered fermentation profile than dietary fibre alone.
Introduction
Whole grain foods have been associated in epidemiological studies with the prevention of cardiovascular disease, obesity and type II diabetes (Anderson et al., 2000; McKeown et al., 2002; Koh-Banerjee and Rimm, 2003) . One of the characteristics of whole grain foods is their relatively high content of resistant starch (RS), if unprocessed (Livesey et al., 1995) , and of non-starch polysaccharides (NSP). These components were related in intervention studies to improved insulin sensitivity (Robertson et al., 2003 (Robertson et al., , 2005 Ito et al., 2006; Weickert et al., 2006) and glucose tolerance (Brighenti et al., 2006; Nilsson et al., 2006) . Furthermore, effects on lipid metabolism in adipocytes (Kabir et al., 1998; Higgins et al., 2006) and postprandial lipid oxidation (Higgins et al., 2004) are reported. It is likely that those effects of NSP and RS are mediated through fermentation of RS and NSP in the colon, which results in the production of the short-chain fatty acids (SCFA) acetate, propionate and butyrate. There is emerging evidence that SCFA not only exert effects in the colonic epithelial cells, but also enter the circulation and can influence metabolic processes in other tissues and organs. Effects of acetate and propionate on glucose and lipid metabolism in the liver have been reported (Anderson and Bridges, 1984; Wolever et al., 1989; Nishina and Freedland, 1990; Venter, 1990; Kok et al., 1996; Fushimi et al., 2006) . Acetate is used in the liver as substrate for the synthesis of cholesterol and fatty acids, whereas it seems that propionate inhibits these processes (Nishina and Freedland, 1990) . Effects of SCFA on adipose tissue metabolism are likely as SCFA have been identified to be ligands for the orphan G protein-coupled receptor GPR41, which is primarily expressed in adipose tissue (Brown et al., 2003) , and stimulation of leptin production in adipocytes by propionate (not acetate) has been described (Xiong et al., 2004) . As adipose tissue is known to secrete various signalling peptides influencing among others insulin sensitivity, feeding behaviour and inflammation (Gimeno and Klaman, 2005) , it could constitute an important link between SCFA production and peripheral metabolic effects.
To investigate the interaction between colonic SCFA production and peripheral tissue, it is necessary to obtain information about the extent to which fermentation-derived SCFA reach systemic circulation. Furthermore, as different SCFA can exert different and even opposing effects, information is needed as to how different fermentable substrates affect these SCFA patterns in the circulation.
Recently, we developed new analytical methods to determine low-level enrichment of 13 C-SCFA in human plasma and urine (Morrison et al., 2004; Ferchaud-Roucher et al., 2006) . These methods were applied to test the hypothesis that ingestion of a test meal with a high content of NSP results in a different 13 C-SCFA plasma profile than a test meal that in addition contains RS.
13 C-enriched barley was obtained by culturing plants under 13 CO 2 -enriched atmosphere for the test meals. The test meals administered were intact cooked barley kernels (high RS and NSP) and barley porridge (high NSP).
Materials and methods

Subjects
Five healthy volunteers with a mean age of 25±7 years and body mass index of 22.4 ± 2.4 participated in the study. None of the subjects had a history of gastrointestinal or metabolic disease or earlier surgery (except for appendectomy). The subjects were free of antibiotics or any other medical treatment influencing gut transit or intestinal microbiota for at least 3 months. The study protocol complied with the Helsinki Declaration and was approved by the Ethics Committee of the University of Leuven. All subjects gave written informed consent. Each of the subjects performed two tests, respectively, with barley porridge and barley kernels as test meal.
Study design
After an overnight fast, the volunteers presented at the laboratory in which they provided a basal urine sample and two breath samples for measurement of, respectively, H 2 and 13 CO 2 . A catheter was introduced in an antecubital vein and a basal blood sample was withdrawn. Consequently, the volunteers received a test meal prepared from 13 C-labelled barley as well as a glass of water. The test meal was always consumed within 20 min. Blood samples were collected every hour during the first 5 h, every 20 min from 5 to 8 h and every 40 min from 8 up to 14 h. Breath samples were collected every 20 min up to 6 h for analysis of 13 CO 2 and up to 10 h for analysis of H 2 . Three volunteers collected all urine for 24 h in different fractions using specified receptacles to which neomycin was added for prevention of bacterial growth. After 6, 9 and 12 h, a standard, light and nonfermentable meal was offered to the volunteers (sandwich with ham or cheese). Unlimited access to water was allowed from 6 h after the start of the test. Preparation of test meals. A barley pearling machine was used to remove the outer hull of the barley kernels. For the porridge, pearl barley kernels were milled in an electric household grain mill (SAMAP Elsässer grain mill F 100) on the finest grade. Barley porridge was prepared by addition of about 86 g of flour to 450 ml water along with 1 g of NaCl after which this portion was cooked in a microwave oven for 5 min at 600 W. For the barley kernel, test meal about 86 g of pearl barley kernels were boiled at low temperature in 320 ml of water until all water was absorbed by the kernels.
Analytical procedures
Analysis of breath samples. Breath was collected in Exetainers (PDZ, Cheshire, UK). The 13 C-breath content was determined by isotope ratio mass spectrometry (ABCA, PDZ, Cheshire, UK). We assumed CO 2 production to be 300 mmol/m 2 body surface area per hour (Ghoos et al., 1993) . The body surface area was calculated by the weightheight formula of Haycock et al. (1978) . The results for digestion of barley were expressed as the cumulative percentage of administered dose of 13 C excreted over 6 h, the maximal excretion rate of 13 C and the time to maximal excretion rate of 13 C. The amount of administered dose of 13 C was calculated taking into account the known enrichment of the labelled barley and the fact that an 86-g portion of barley contains 56 g of total starch. Hydrogen was measured in an H 2 -monitor (MEC, Brussels, Belgium) and expressed in parts per million.
Oro-cecal transit time (OCTT, that is the time that elapses between intake of a meal and arrival of the meal in the colon) was calculated on the basis of H 2 -excretion as described earlier (Geypens et al., 1999) .
Analysis of SCFA concentrations in plasma samples. Concentrations of SCFA were determined on a gas chromatographymass spectrometry (Hewlett Packard, Palo Alto, CA, USA) using electron impact ionization as described earlier (Ferchaud-Roucher et al., 2005) .
Analysis of
13 C-enrichment in plasma samples. After addition of 200 ml of NaCl (4 M) (X99.8% purity, Sigma-Aldrich) to 1 ml of plasma, proteins were removed by centrifugation at 4575 g for 2 h 40 min using Amicon centrifugal filter devices YM-30 (Millipore, Bedford, MA, USA). Plasma ultrafiltrates were concentrated to 200 ml under a nitrogen stream and acidified to pH 2.5-3 by adding 10 ml of HCl (2 M). SPME fibre (CAR/PDMS from Supelco; Bellefonte, PA, USA) was exposed to the analytes by immersion in the sample at 40 1C for 45 min. The SCFA adsorbed on the SPME fibre were injected by direct desorption into a gas chromatography (HP 5890, Hewlett Packard). The 13 C-SCFA analysis was performed using a gas chromatography-combustionisotope ratio mass spectrometry (Delta S, Finnigan MAT, Bremen, Germany) (Ferchaud-Roucher et al., 2006) .
Calculation of the enrichment of 13 C-SCFA. The data were obtained using the formula: The isotopic enrichment in a sample as compared with the basal value is given in atom percent excess (APE):
Finally, plasma 13 C-SCFA concentrations were calculated by multiplying the APE of the respective SCFA with its plasma concentration.
Analysis of urine samples. SCFA concentration and 13 C abundance were measured in urine after the method of Morrison et al. (2004) .
Statistical analysis
The results are expressed as mean values and s.d. Owing to the small number of subjects, non-parametric statistical evaluation (Wilcoxon's test and Mann-Witney's test) was performed using SPSS software (SPSS 15.0 for Windows; SPSS Inc., Chicago, IL, USA). The level for statistical significance was set at Po0.05. Differences for which P-values were o0.1 were considered as tendencies.
Results
Oro-cecal transit time OCTT was calculated on the basis of an increase in H 2 -excretion. No statistically significant differences were observed in OCTT values of barley porridge (360±47 min) as compared with barley kernels (372 ± 18 min) (P ¼ 0.705).
Digestion of administered
13 C-barley. The cumulative 13 C-excretion (33.9±19.5 vs 26.7±15.1% of administered dose) as well as the peak excretion (7.9 ± 4.9 vs 6.3 ± 3.6% of administered dose per hour) were not significantly different for 13 C-barley porridge and for 13 C-barley kernels, suggesting no difference in the ultimate quantity of tracer oxidized. The time to maximal 13 C-excretion was significantly shorter for the porridge meal (200±32 min) indicating a faster digestion than that of the kernel meal (300±42 min) (P ¼ 0.043).
C-SCFA concentrations in plasma
The plasma concentrations of 13 C-SCFA are presented in Figure 1 .
After administration of both test meals, an increase in 13 C-acetate was already observed in the early phase (o360 min) (Figure 1a) . A second peak in 13 C-acetate concentration was observed in the later phase (4360 min) and was higher after the barley kernel test meal than after the barley porridge test meal. The cumulative plasma concentration tended to be higher after barley kernels (P ¼ 0.064). A rise in 13 C-propionate concentration was detected after the barley porridge meal for only three volunteers, but never in the plasma after the barley kernels meal (Figure 1b ). An increase of 13 C-butyrate concentration was only found in the later phase (4360 min) and was comparable after the barley kernels and barley porridge meal (Figure 1c) . Consequently, cumulative 13 C-butyrate plasma concentrations were not different for both meals (P ¼ 0.65). The proportion of 13 C-acetate of total 13 C-SCFA in plasma was 99% after barley kernels and 98.3% after barley porridge.
Excretion of 13 C-SCFA in urine
Figures 2a-c show the cumulative urinary excretion of the respective 13 C-SCFA. Cumulative 13 C-acetate excretion after 24 h was similar after both meals (P ¼ 0.57). However, after barley porridge, 13 C-acetate excretion proceeded somewhat faster than after barley kernels, which is in agreement with the higher 13 C-acetate plasma concentrations in the early phase. Unlike in plasma, 13 C-propionate was retrieved in urine after both meals, although in lower concentrations SCFA profiles in healthy volunteers K Verbeke et al after barley kernels. A tendency towards a higher cumulative excretion after barley porridge than after barley kernels was observed (P ¼ 0.098). The urinary excretion of 13 C-butyrate was borderline significantly higher after barley kernels (P ¼ 0.057).
Also in urine, 13 C-acetate was by far the most predominant 13 C-SCFA (97.4% of total 13 C-SCFA after barley kernels and 93.5% after barley porridge).
Discussion
In vitro fermentation studies using human (Weaver et al., 1992; Velazquez et al., 2000; Pylkas et al., 2005) or swine inocula (Smiricky-Tjardes et al., 2003) have shown that the amounts and the pattern of SCFA production vary among different types of fermentable carbohydrate. Similarly, the type of indigestible carbohydrate consumed was found to influence the distribution of SCFA in the hindgut of rats (Henningsson et al., 2002) and pigs (Bird et al., 2004) .
Owing to the inaccessibility of the colon in healthy, freeliving human beings, it is difficult to estimate the colonic production profile of SCFA and their bioavailability to the host. Stable isotope tracer techniques have been suggested as a way to estimate the colonic acetate production (Pouteau et al., 1998) and the whole body acetate flux (Morrison et al., 2004) . Ahmed et al. (2000) studied colonic SCFA formation in patients with left-sided colectomy and found a higher SCFA production and in particular butyrate production after a high-RS diet as compared with a low-RS diet. Pomare et al. (1985) measured venous blood SCFA in human beings after administration of beverages containing SCFA or fermentable carbohydrates, but only found a rise in acetate concentrations.
In this study, we measured 13 C-labelled SCFA after administration of labelled barley porridge and barley kernels. The use of isotopes allowed to selectively detect SCFA derived from colonic fermentation with high sensitivity.
Barley porridge is rich in NSP, whereas barley kernels contain RS in addition to NSP. The 13 CO 2 -excretion data showed that the porridge test meal was digested faster as compared with the kernel test meal (shorter time to peak excretion), which is in agreement with the higher amount of rapidly available glucose in the porridge meal Supplementary Information) . In contrast, the extent of digestion was relatively similar for both test meals (similar cumulative 13 C-excretion). The amount of substrate reaching the colon may have been similar in both occasions; however, the profile of enriched SCFA in plasma differed depending on the test meal administered. On the basis of several studies suggesting that RS is a good source for butyrate production (Weaver et al., 1992; Casterline et al., 1997; De Schrijver et al., 1999; Brouns et al., 2002) , we assumed a higher colonic 13 C-butyrate production after the barley kernel meal than after the porridge meal. Nevertheless, plasma 13 C-butyrate concentrations were rather similar after both meals. A similar pattern was observed in urinary 13 C-butyrate excretion up to 12 h. However, urinary 13 C-butyrate excretion from 12 to 24 h tended to be higher after barley kernels than after barley porridge (P ¼ 0.074), suggesting that butyrate production in the colon proceeds slower than acetate or propionate production. This might be explained by the fact that butyrate is not produced directly from the fermented carbohydrate, but through conversion of acetate (so-called mechanism of cross-feeding) (Falony et al., 2006; Morrison et al., 2006) .
SCFA profiles in healthy volunteers
In vitro studies have shown that fermentation of barleyderived b-glucans by human faecal microbiota yields SCFA in a molar ratio of acetate:propionate:butyrate of 51:32:17 (Hughes et al., 2008) , which is considered propionate rich. However, the 13 C-SCFA were retrieved in plasma as well as in urine in a molar ratio of acetate:propionate:butyrate of 98:1:1, reflecting the considerable differential absorption and metabolism in colonic epithelial cells and liver.
Data on 13 C-enrichment of SCFA in urine confirmed the observed difference in SCFA profile after the two test meals. Interestingly, 13 C-enriched propionate was also observed in urine after the barley kernel test meal, although to a lower extent than after the porridge meal. The measurement of low 13 C enrichment involves subtraction of basal 13 C abundance from each analysis. At low SCFA concentrations (as occurs with propionate and butyrate), this results in larger errors in estimating enrichment. However, the generally good agreement between plasma and urinary data, which were analysed in different laboratories, suggests that analysis of urinary SCFA enrichment profiles provides an adequate and noninvasive way to monitor the availability of SCFA to the host. This observation confirms earlier data in which a similar whole body acetate flux was obtained from measurement of urine or plasma tracer enrichments (Morrison et al., 2004) .
The OCTT of both test meals was measured to allow correlation of changes in plasma 13 C-SCFA concentrations to the digestion phase (before OCTT) or the fermentation phase (after OCTT). OCTT values were similar for both test meals and amounted to approximately 6 h.
When looking at the kinetics of appearance of 13 C-labelled SCFA in the circulation, it was found that plasma concentration of 13 C-acetate was already increased as early as after 3 h, that is during the early phase when digestion would be thought to dominate (o6 h). 13 C-acetate could be derived from early bacterial degradation of the test meal, a hypothesis that is favoured by the concomitant appearance of labelled propionate and butyrate, albeit to a lesser extent. In addition, all labelled SCFA were found in the 0-6 h urine fraction as well. It is not clear whether this early fermentation should be due to an easily fermentable compound of the test meal, to rapid transit of the head of the meal, to rapid transit of a soluble component of the (soluble fibre rich) meal or to fermentation in the small intestine in which, in the more distal parts, the density of bacterial populations lies between 10 4 and 10 8 cells/ml (as compared with 10 12 cells/ ml in the colon) (Tannock, 1995) . The methodology used in this study allowed quantitative description of the SCFA reaching the circulation after consumption of a test meal rich in indigestible carbohydrates. To be able to relate colonic SCFA production and SCFA availability to the effects of SCFA on peripheral tissues, it will be necessary to further adapt the methodology, probably by in vivo application of known quantities of isotope-labelled SCFA. In conclusion, the method described in this study allows to evaluate SCFA profiles obtained after administration of different indigestible carbohydrates in healthy human beings. The results of this study have clearly shown that meals containing dietary fibre combined with RS result in altered SCFA profiles as compared with meals containing dietary fibre alone.
